Efficacy and Safety of Garsorasib in Patients with KRAS G12C-Mutated Advanced Pancreatic Cancer

0
46
Garsorasib demonstrated encouraging antitumor activity and a tolerable safety profile in patients with KRAS G12C-mutated advanced pancreatic cancer.
[British Journal of Cancer]
Abstract